Texas Oncology-Baylor Charles A Sammons Cancer Center — Dallas, Texas

Texas Oncology-Baylor Charles A Sammons Cancer Center is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology-Baylor Charles A Sammons Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Baylor Charles A Sammons Cancer Center?

Texas Oncology-Baylor Charles A Sammons Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Baylor Charles A Sammons Cancer Center conducted?

Texas Oncology-Baylor Charles A Sammons Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Is Texas Oncology-Baylor Charles A Sammons Cancer Center accredited by Crixeo Health?

Texas Oncology-Baylor Charles A Sammons Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Baylor Charles A Sammons Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.